First, the murine precursor of Gatipotuzumab as bound to TA-MUC1 induces antibody-dependent-cell-mediated cytotoxicity (ADCC) and phagocytosis (ADCP) leading to cytolysis of the cancer cell [2]. The gene discussed is MUC1; the disease is cancer.